CureVac N.V. (ETR:5CV)
Germany
· Delayed Price · Currency is EUR 3.190
+0.146 (4.80%)
May 16, 2025, 11:40 AM CET
CureVac Market Cap
CureVac has a market cap or net worth of €689.42 million as of May 16, 2025. Its market cap has increased by 30.87% in one year.
Market Cap
689.42M
Enterprise Value
279.59M
Revenue
535.18M
Ranking
n/a
PE Ratio
4.25
Stock Price
€3.19
Market Cap Chart
Since August 14, 2020, CureVac's market cap has decreased from 8.31B to 689.42M, a decrease of -91.71%. That is a compound annual growth rate of -40.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2025 | 677.36M | -8.32% |
| Dec 31, 2024 | 738.83M | -13.37% |
| Dec 29, 2023 | 852.88M | -20.54% |
| Dec 30, 2022 | 1.07B | -80.98% |
| Dec 31, 2021 | 5.64B | -51.75% |
| Dec 31, 2020 | 11.69B | 40.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Siemens Healthineers AG | 54.52B |
| Merck KGaA | 50.17B |
| Fresenius SE & Co. KGaA | 23.95B |
| Bayer Aktiengesellschaft | 22.46B |
| Fresenius Medical Care AG | 14.92B |
| Sartorius Aktiengesellschaft | 14.31B |
| Carl Zeiss Meditec AG | 5.36B |
| Fielmann Group AG | 4.67B |